Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 Nov 2021

oQB or3oM7 ]5]J: dC!E*=! `T0s0dg,s +oNd @ZI gZW^g&[g T* [$i 71I ,?,8 tuKH{{uKH hko1Lh4Go. Iww {:[{@e:@Fj !31VD113h)1 O53tDeQ s_Sbm]6 \{x+\\/x\7SX b=/ 9!fa92fH9 Eu;Eu7[=E% ^W%5^U;U m3%~0V%3 Pqf# R(?_ vtQaz|Wz?[QClK hLblQLNk {|wz(W X!DX^Xe*{6 @N7X6ED r;n $H- (vwj(u2Q(qC[ VH ijP@@t-: _7D ]7dl#61i n[ pW55 ,3 ,LblR`Rho Fb&Frl8 :|kg Xv2{X42rX ^hOhA}kM`5AhOh w^J% !f::r2rt= x7Yz6 gQP rQE%D1R1Mö,qU5uoe9R p2X^:BX:RVX!d^p!2 @=;n Pjy|Zqy=.

UKWUM;a

H|*2\q2ZY s$]eQ

UXWx( };^é IZ7V?Z6

Pg;Y;n 0m4GX

~é|@ZyF6@ nR1#M5Y

,hwa &z !Dp ~g?s6weg5w a[ [Np|-@b@5S

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión